Surgical treatment of gallbladder cancer： Current status and advances

Xiaoyu YIN; Qiongcong XU

doi:10.12449/JCH241205

Volume 40 Issue 12

Dec. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(12): 2366-2370

PDF( 612 KB)

Surgical treatment of gallbladder cancer： Current status and advances

DOI: 10.12449/JCH241205

Xiaoyu YIN^{,
,},
Qiongcong XU

Department of Pancreatobiliary Surgery，The First Affiliated Hospital of Sun Yat-sen University，Guangzhou 510080，China

More Information

Corresponding author: YIN Xiaoyu， yinxy@mail.sysu.edu.cn （ORCID： 0000-0002-5518-5984）
Received Date: 2024-10-15
Accepted Date: 2024-10-25
Published Date: 2024-12-25

Abstract

Abstract

Gallbladder cancer is a malignant tumor with an extremely poor prognosis， and radical surgery remains the only potentially curative treatment method for this disease. For stage Tis and T1a gallbladder cancer， cholecystectomy alone can achieve a curative effect； for stage T1b-T2 gallbladder cancer， radical surgery （including resection of the gallbladder， partial hepatectomy， and regional lymphadenectomy） remains the preferred treatment modality； for stage T3-T4 gallbladder cancer， extended radical resection helps to improve the prognosis of some patients， but with a high risk and a high incidence rate of complications， and it is necessary to grasp the indications and conduct surgery by a team with rich experience in pancreatobiliary surgery. There are currently still controversies over the application of minimally invasive surgery in the treatment of gallbladder cancer； however， an increasing number of evidence has shown that minimally invasive surgery for gallbladder cancer is safe and feasible in centers with extensive experience in minimally invasive techniques. This article systematically elaborates on the current status and advances in the surgical treatment of gallbladder cancer based on the authors’ clinical experience and related articles.
- Gallbladder Neoplasms,
- Surgical Procedures， Operative,
- Therapeutics

FullText(HTML)

References(44)

References

[1]	MISRA S, CHATURVEDI A, MISRA NC, et al. Carcinoma of the gallbladder[J]. Lancet Oncol, 2003, 4( 3): 167- 176. DOI: 10.1016/s1470-2045(03)01021-0.
[2]	HUNDAL R, SHAFFER EA. Gallbladder cancer: Epidemiology and outcome[J]. Clin Epidemiol, 2014, 6: 99- 109. DOI: 10.2147/CLEP.S37357.
[3]	SHAFFER EA. Gallbladder cancer: The basics[J]. Gastroenterol Hepatol(N Y), 2008, 4( 10): 737- 741.
[4]	DI MAURO D, ORABI A, MYINTMO A, et al. Routine examination of gallbladder specimens after cholecystectomy: A single-centre analysis of the incidence, clinical and histopathological aspects of incidental gallbladder carcinoma[J]. Discov Oncol, 2021, 12( 1): 4. DOI: 10.1007/s12672-021-00399-5.
[5]	LI B, ZOU WL, ZUO S. Advances and challenges in surgical management of unexpected gallbladder cancer[J]. J Clin Surg, 2022, 30( 11): 1016- 1019. DOI: 10.3969/j.issn.1005-6483.2022.11.005. 李博, 邹卫龙, 左石. 意外胆囊癌外科治疗的进展和挑战[J]. 临床外科杂志, 2022, 30( 11): 1016- 1019. DOI: 10.3969/j.issn.1005-6483.2022.11.005.
[6]	FUKS D, REGIMBEAU JM, LE TREUT YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 study group[J]. World J Surg, 2011, 35( 8): 1887- 1897. DOI: 10.1007/s00268-011-1134-3.
[7]	VEGA EA, SANHUEZA M, VIÑUELA E. Minimally invasive surgery for gallbladder cancer[J]. Surg Oncol Clin N Am, 2019, 28( 2): 243- 253. DOI: 10.1016/j.soc.2018.11.001.
[8]	GENG ZM, LEI JJ, ZHANG D, et al. Current status and controversies of minimally invasive surgery for gallbladder cancer[J]. J Southwest Med Univ, 2024, 47( 2): 93- 97. DOI: 10.3969/j.issn.2096-3351.2024.02.001. 耿智敏, 雷建军, 张东, 等. 胆囊癌微创手术治疗的现状与争议[J]. 西南医科大学学报, 2024, 47( 2): 93- 97. DOI: 10.3969/j.issn.2096-3351.2024.02.001.
[9]	POUDEL R, SHAH A. Incidence of incidental gall bladder cancer and role of routine histopathological examination in cholecystectomies specimens for benign disease[J]. J Nepal Health Res Counc, 2020, 18( 3): 547- 550. DOI: 10.33314/jnhrc.v18i3.1974.
[10]	YIN XY. Managements for the incidental gallbladder carcinoma during or after cholecystectomy[J]. Chin J Pract Surg, 2015, 35( 9): 942- 945. DOI: 10.7504/CJPS.ISSN1005-2208.2015.09.09. 殷晓煜. 胆囊切除术中及术后意外胆囊癌的处理[J]. 中国实用外科杂志, 2015, 35( 9): 942- 945. DOI: 10.7504/CJPS.ISSN1005-2208.2015.09.09.
[11]	LEE SE, KIM KS, KIM WB, et al. Practical guidelines for the surgical treatment of gallbladder cancer[J]. J Korean Med Sci, 2014, 29( 10): 1333- 1340. DOI: 10.3346/jkms.2014.29.10.1333.
[12]	Branch of Biliary Surgery, Chinese Surgical Society; Chinese Committee of Biliary Surgeons. Guideline for the diagnosis and treatment of gallbladder carcinoma(2019 edition)[J]. Chin J Surg, 2020, 58( 4): 243- 251. DOI: 10.3760/cma.j.cn112139-20200106-00014. 中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58( 4): 243- 251. DOI: 10.3760/cma.j.cn112139-20200106-00014.
[13]	WANG HJ, ZHANG BH, GU ML, et al. Prevention and surgical treatment of unexpected gallbladder carcinoma[J]. J Hepatopancreatobiliary Surg, 2021, 33( 4): 197- 199, 204. DOI: 10.11952/j.issn.1007-1954.2021.04.002. 王恒杰, 张宝华, 顾卯林, 等. 意外胆囊癌的防范和外科治疗[J]. 肝胆胰外科杂志, 2021, 33( 4): 197- 199, 204. DOI: 10.11952/j.issn.1007-1954.2021.04.002.
[14]	YIN XY. Applications and values of combined excision of extra-hepatic bile duct in curative resection of gallbladder carcinoma[J]. Chin J Pract Surg, 2016, 36( 10): 1048- 1050. DOI: 10.7504/CJPS.ISSN1005-2208.2016.10.08. 殷晓煜. 肝外胆管切除在胆囊癌根治性切除术中的应用与价值[J]. 中国实用外科杂志, 2016, 36( 10): 1048- 1050. DOI: 10.7504/CJPS.ISSN1005-2208.2016.10.08.
[15]	KIM HS, PARK JW, KIM H, et al. Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study[J]. J Hepatobiliary Pancreat Sci, 2018, 25( 12): 533- 543. DOI: 10.1002/jhbp.593.
[16]	WAKAI T, SHIRAI Y, YOKOYAMA N, et al. Early gallbladder carcinoma does not warrant radical resection[J]. Br J Surg, 2001, 88( 5): 675- 678. DOI: 10.1046/j.1365-2168.2001.01749.x.
[17]	OUCHI K, MIKUNI J, KAKUGAWA Y, et al. Laparoscopic cholecystectomy for gallbladder carcinoma: Results of a Japanese survey of 498 patients[J]. J Hepatobiliary Pancreat Surg, 2002, 9( 2): 256- 260. DOI: 10.1007/s005340200028.
[18]	GOETZE TO, PAOLUCCI V. Immediate re-resection of T1 incidental gallbladder carcinomas: A survival analysis of the German registry[J]. Surg Endosc, 2008, 22( 11): 2462- 2465. DOI: 10.1007/s00464-008-9747-9.
[19]	MATSUYAMA R, MATSUO K, MORI R, et al. Incidental gallbladder cancer on cholecystectomy: Strategy for re-resection of presumed benign diseases from a retrospective multicenter study by the Yokohama clinical oncology group[J]. In Vivo, 2021, 35( 2): 1217- 1225. DOI: 10.21873/invivo.12372.
[20]	GOEL M, PANDROWALA S, PATEL P, et al. Node positivity in T1b gallbladder cancer: A high volume centre experience[J]. Eur J Surg Oncol, 2022, 48( 7): 1585- 1589. DOI: 10.1016/j.ejso.2022.03.013.
[21]	CHO JK, LEE W, JANG JY, et al. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: A retrospective study[J]. World J Surg Oncol, 2019, 17( 1): 8. DOI: 10.1186/s12957-018-1556-6.
[22]	LEE W, JEONG CY, JANG JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study[J]. Surgery, 2017, 162( 3): 515- 524. DOI: 10.1016/j.surg.2017.05.004.
[23]	LIU CM, DONG JM, CHAI YJ, et al. Advances and reflections on surgical treatment of gallbladder cancer[J]. Zhejiang Med J, 2023, 45( 3): 332- 336. DOI: 10.12056/j.issn.1006-2785.2023.45.3.2022-2736. 刘晨鸣, 董家铭, 柴应杰, 等. 胆囊癌外科治疗的进展和思考[J]. 浙江医学, 2023, 45( 3): 332- 336. DOI: 10.12056/j.issn.1006-2785.2023.45.3.2022-2736.
[24]	SONG TQ. Progress in surgical treatment of gallbladder cancer[J]. J Hepatobiliary Surg, 2020, 28( 6): 407- 411. DOI: 10.3969/j.issn.1006-4761.2020.06.004. 宋天强. 胆囊癌外科治疗进展[J]. 肝胆外科杂志, 2020, 28( 6): 407- 411. DOI: 10.3969/j.issn.1006-4761.2020.06.004.
[25]	YUZA K, SAKATA J, PRASOON P, et al. Long-term outcomes of surgical resection for T1b gallbladder cancer: An institutional evaluation[J]. BMC Cancer, 2020, 20( 1): 20. DOI: 10.1186/s12885-019-6507-2.
[26]	XU L, TAN HD, LIU XL, et al. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database(2004 to 2013)[J]. Cancer Med, 2020, 9( 11): 3668- 3679. DOI: 10.1002/cam4.2989.
[27]	BENSON AB, D’ANGELICA MI, ABBOTT DE, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19( 5): 541- 565. DOI: 10.6004/jnccn.2021.0022.
[28]	CHIBA N, SHIMAZU M, OCHIAI S, et al. Resection of hepatic lesions perfused by the cholecystic vein using indocyanine green navigation in patients with cT2 gallbladder cancer[J]. World J Surg, 2019, 43( 2): 608- 614. DOI: 10.1007/s00268-018-4810-8.
[29]	JIANG XQ, HU MT, WANG JH. Application value and controversy of extended radical surgery for gallbladder cancer[J]. Chin J Pract Surg, 2023, 43( 11): 1233- 1237. DOI: 10.19538/j.cjps.issn1005-2208.2023.11.07. 姜小清, 胡明泰, 王敬晗. 胆囊癌行扩大根治术的应用价值及争议[J]. 中国实用外科杂志, 2023, 43( 11): 1233- 1237. DOI: 10.19538/j.cjps.issn1005-2208.2023.11.07.
[30]	D’ANGELICA M, DALAL KM, DEMATTEO RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder[J]. Ann Surg Oncol, 2009, 16( 4): 806- 816. DOI: 10.1245/s10434-008-0189-3.
[31]	REDDY SK, MARROQUIN CE, KUO PC, et al. Extended hepatic resection for gallbladder cancer[J]. Am J Surg, 2007, 194( 3): 355- 361. DOI: 10.1016/j.amjsurg.2007.02.013.
[32]	ALOIA TA, JÁRUFE N, JAVLE M, et al. Gallbladder cancer: Expert consensus statement[J]. HPB(Oxford), 2015, 17( 8): 681- 690. DOI: 10.1111/hpb.12444.
[33]	NIGRI G, BERARDI G, MATTANA C, et al. Routine extra-hepatic bile duct resection in gallbladder cancer patients without bile duct infiltration: A systematic review[J]. Surgeon, 2016, 14( 6): 337- 344. DOI: 10.1016/j.surge.2016.06.004.
[34]	MIZUNO T, EBATA T, YOKOYAMA Y, et al. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer[J]. Br J Surg, 2019, 106( 5): 626- 635. DOI: 10.1002/bjs.11088.
[35]	FERNANDES EDE S, MELLO FT, RIBEIRO-FILHO J, et al. The largest western experience with hepatopancreatoduodenectomy: Lessons learned with 35 cases[J]. Arq Bras Cir Dig, 2016, 29( 1): 17- 20. DOI: 10.1590/0102-6720201600010005.
[36]	D’ANGELICA M, MARTIN RC 2, JARNAGIN WR, et al. Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer[J]. J Am Coll Surg, 2004, 198( 4): 570- 576. DOI: 10.1016/j.jamcollsurg.2003.11.022.
[37]	BERGER-RICHARDSON D, CHESNEY TR, ENGLESAKIS M, et al. Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review[J]. Surgery, 2017, 161( 3): 618- 627. DOI: 10.1016/j.surg.2016.08.007.
[38]	LUNDBERG O, KRISTOFFERSSON A. Wound recurrence from gallbladder cancer after open cholecystectomy[J]. Surgery, 2000, 127( 3): 296- 300. DOI: 10.1067/msy.2000.104487.
[39]	ZHAO X, LI XY, JI W. Laparoscopic versus open treatment of gallbladder cancer: A systematic review and meta-analysis[J]. J Minim Access Surg, 2018, 14( 3): 185- 191. DOI: 10.4103/jmas.JMAS_223_16.
[40]	CHEE MYM, WU AGR, FONG KY, et al. Robotic, laparoscopic and open surgery for gallbladder cancer: A systematic review and network meta-analysis[J]. Surg Endosc, 2024, 38( 9): 4846- 4857. DOI: 10.1007/s00464-024-11162-6.
[41]	AHMED SH, USMANI SUR, MUSHTAQ R, et al. Role of laparoscopic surgery in the management of gallbladder cancer: Systematic review& meta-analysis[J]. Am J Surg, 2023, 225( 6): 975- 987. DOI: 10.1016/j.amjsurg.2023.01.008.
[42]	VEGA EA, DE ARETXABALA X, QIAO W, et al. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer[J]. Br J Surg, 2020, 107( 3): 289- 300. DOI: 10.1002/bjs.11379.
[43]	ZHANG CW. Application of minimally invasive surgery in radical resection of gallbladder cancer[J]. Zhejiang Med J, 2023, 45( 18): 1905- 1909, 1920. DOI: 10.12056/j.issn.1006-2785.2023.45.18.2023-1453. 张成武. 微创手术在胆囊癌根治性切除术中的应用[J]. 浙江医学, 2023, 45( 18): 1905- 1909, 1920. DOI: 10.12056/j.issn.1006-2785.2023.45.18.2023-1453.
[44]	WANG J, LI Z, CHEN LL, et al. Comparing robotic and open surgical techniques in gallbladder cancer management: A detailed systematic review and meta-analysis[J]. J Robot Surg, 2024, 18( 1): 111. DOI: 10.1007/s11701-024-01851-8.

Relative Articles

[1]	Xueying LIU, Huihui SHI, Haowen WANG, Tao YANG. The material basis and toxic mechanism of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1512-1518. doi: 10.12449/JCH240802
[2]	Chenghai LIU. Research advances and challenges in herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1505-1511. doi: 10.12449/JCH240801
[3]	Yinuo DONG, Yang ZHI, Jieting TANG, Yimin MAO. Diagnosis of herb-induced liver injury： Challenges in practice[J]. Journal of Clinical Hepatology, 2024, 40(8): 1533-1537. doi: 10.12449/JCH240805
[4]	Tingting HE, Zhaofang BAI, Jiabo WANG, Xiaohe XIAO. Phenotypic characteristics and toxicological mechanisms of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1525-1532. doi: 10.12449/JCH240804
[5]	Xin SUN, Qiong LUO, Tao YANG, Chenghai. LIU. Management and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1538-1542. doi: 10.12449/JCH240806
[6]	Hui ZHENG, Rong SUN. Influence of combined drug administration on herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1519-1524. doi: 10.12449/JCH240803
[7]	Zhaofang BAI, Xiaoyan ZHAN, Guiji LYU, Yongping YANG. Blocking and reversing liver fibrosis with traditional Chinese medicine compound prescriptions: Beyond the known frontiers[J]. Journal of Clinical Hepatology, 2023, 39(2): 273-277. doi: 10.3969/j.issn.1001-5256.2023.02.004
[8]	Junhong LIU, Xinyu LI, Miaolei WANG, Boya FU, Linman LI, Hui FANG. Advantages and characteristics of traditional Chinese medicine in the treatment of liver fibrosis[J]. Journal of Clinical Hepatology, 2023, 39(2): 267-272. doi: 10.3969/j.issn.1001-5256.2023.02.003
[9]	Ying FENG, Ke SHI, Xiaohua ZHANG, Li YANG, Xianbo. WANG. Effect of anti-liver fibrosis traditional Chinese medicine therapy on the prognosis of patients with liver cirrhosis and superior mesenteric venous thrombosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1534-1539. doi: 10.3969/j.issn.1001-5256.2022.07.015
[10]	Luo Qiong, Zhu GeRui, Gu HongTu, Liu Kun, Chen GaoFeng, Xing Feng, Tao YanYan, Liu ChengHai. Liver histopathological features of patients with drug-induced liver injury due to Chinese herbal medicine or Western medicine: A comparative analysis of 50 cases[J]. Journal of Clinical Hepatology, 2020, 36(3): 596-601. doi: 10.3969/j.issn.1001-5256.2020.03.025
[11]	Liu ChengHai, Zhao ZhiMin, Lyu Jing. Advances in the understanding and treatment of liver fibrosis in traditional Chinese medicine[J]. Journal of Clinical Hepatology, 2019, 35(4): 728-733. doi: 10.3969/j.issn.1001-5256.2019.04.006
[12]	Sheng QingShou, Lai GuoQuan, Yu XueJing, Wei Cui. The role of traditional Chinese medicine in regulating cytokines associated with liver fibrosis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2677-2680. doi: 10.3969/j.issn.1001-5256.2018.12.037
[13]	Chen Jun. Drug-induced liver injury caused by Chinese herbal medicine cannot be neglected[J]. Journal of Clinical Hepatology, 2018, 34(6): 1169-1171. doi: 10.3969/j.issn.1001-5256.2018.06.006
[14]	Liu ChengHai, Zhu ChunWu. Epidemic features, major causes, and diagnostic evaluation of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(5): 829-832. doi: 10.3969/j.issn.1001-5256.2017.05.007
[15]	Zhu Yun, Wang RuiLin, Sun XueYing, Yu SiMiao, Jing Jing, Wang JiaBo, He TingTing, Huang YiXue, Wang LiPing, Sun YongQiang. Guiding significance of Guideline for diagnosis and treatment of herb-induced liver injury in clinical diagnosis: a retrospective analysis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2159-2162. doi: 10.3969/j.issn.1001-5256.2016.11.032
[16]	Branch of Hepatobiliary Diseases, China Association of Chinese Medicine, Branch of Chinese Patent Medicine, China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(5): 835-843. doi: 10.3969/j.issn.1001-5256.2016.05.003
[17]	Li Yang, Xu JianMing. Clinical analysis of 11 cases of hepatic veno-occlusive disease caused by Chinese herbal medicine[J]. Journal of Clinical Hepatology, 2011, 27(2): 140-142.
[19]	Shen FengJun, Yin ChengHong, Ma Hong, Ma XueMei, Jia JiDong, Wang BaoEn, Zhu YueKe, Liu TianHui. Expression of angiotensin Ⅱ type 1 receptors mRNA in rat experimental biliary fibrosis[J]. Journal of Clinical Hepatology, 2002, 18(5): 279-281.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (441) PDF downloads(67)

Surgical treatment of gallbladder cancer： Current status and advances

DOI: 10.12449/JCH241205

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Surgical treatment of gallbladder cancer： Current status and advances

DOI: 10.12449/JCH241205

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content